Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines

Margaret R. O'Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal Attar, Uma Borate, Steven E. Coutre, Lloyd E. Damon, Jeffrey Lancet, Lori J Maness-Harris, Guido Marcucci, Michael G. Martin, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. StoneStephen A. Strickland, Eunice S. Wang, Kristina M. Gregory, Maoko Naganuma

Research output: Contribution to journalReview article

94 Citations (Scopus)

Abstract

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

Original languageEnglish (US)
Pages (from-to)1047-1055
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number9
DOIs
StatePublished - Sep 1 2013

Fingerprint

Acute Promyelocytic Leukemia
Acute Myeloid Leukemia
Guidelines
Maintenance

ASJC Scopus subject areas

  • Oncology

Cite this

O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., ... Naganuma, M. (2013). Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 11(9), 1047-1055. https://doi.org/10.6004/jnccn.2013.0127

Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines. / O'Donnell, Margaret R.; Tallman, Martin S.; Abboud, Camille N.; Altman, Jessica K.; Appelbaum, Frederick R.; Arber, Daniel A.; Attar, Eyal; Borate, Uma; Coutre, Steven E.; Damon, Lloyd E.; Lancet, Jeffrey; Maness-Harris, Lori J; Marcucci, Guido; Martin, Michael G.; Millenson, Michael M.; Moore, Joseph O.; Ravandi, Farhad; Shami, Paul J.; Smith, B. Douglas; Stone, Richard M.; Strickland, Stephen A.; Wang, Eunice S.; Gregory, Kristina M.; Naganuma, Maoko.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 11, No. 9, 01.09.2013, p. 1047-1055.

Research output: Contribution to journalReview article

O'Donnell, MR, Tallman, MS, Abboud, CN, Altman, JK, Appelbaum, FR, Arber, DA, Attar, E, Borate, U, Coutre, SE, Damon, LE, Lancet, J, Maness-Harris, LJ, Marcucci, G, Martin, MG, Millenson, MM, Moore, JO, Ravandi, F, Shami, PJ, Smith, BD, Stone, RM, Strickland, SA, Wang, ES, Gregory, KM & Naganuma, M 2013, 'Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 11, no. 9, pp. 1047-1055. https://doi.org/10.6004/jnccn.2013.0127
O'Donnell, Margaret R. ; Tallman, Martin S. ; Abboud, Camille N. ; Altman, Jessica K. ; Appelbaum, Frederick R. ; Arber, Daniel A. ; Attar, Eyal ; Borate, Uma ; Coutre, Steven E. ; Damon, Lloyd E. ; Lancet, Jeffrey ; Maness-Harris, Lori J ; Marcucci, Guido ; Martin, Michael G. ; Millenson, Michael M. ; Moore, Joseph O. ; Ravandi, Farhad ; Shami, Paul J. ; Smith, B. Douglas ; Stone, Richard M. ; Strickland, Stephen A. ; Wang, Eunice S. ; Gregory, Kristina M. ; Naganuma, Maoko. / Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2013 ; Vol. 11, No. 9. pp. 1047-1055.
@article{d4fdbe9c18cc4019b90da13ceadb2c35,
title = "Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines",
abstract = "These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.",
author = "O'Donnell, {Margaret R.} and Tallman, {Martin S.} and Abboud, {Camille N.} and Altman, {Jessica K.} and Appelbaum, {Frederick R.} and Arber, {Daniel A.} and Eyal Attar and Uma Borate and Coutre, {Steven E.} and Damon, {Lloyd E.} and Jeffrey Lancet and Maness-Harris, {Lori J} and Guido Marcucci and Martin, {Michael G.} and Millenson, {Michael M.} and Moore, {Joseph O.} and Farhad Ravandi and Shami, {Paul J.} and Smith, {B. Douglas} and Stone, {Richard M.} and Strickland, {Stephen A.} and Wang, {Eunice S.} and Gregory, {Kristina M.} and Maoko Naganuma",
year = "2013",
month = "9",
day = "1",
doi = "10.6004/jnccn.2013.0127",
language = "English (US)",
volume = "11",
pages = "1047--1055",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "9",

}

TY - JOUR

T1 - Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines

AU - O'Donnell, Margaret R.

AU - Tallman, Martin S.

AU - Abboud, Camille N.

AU - Altman, Jessica K.

AU - Appelbaum, Frederick R.

AU - Arber, Daniel A.

AU - Attar, Eyal

AU - Borate, Uma

AU - Coutre, Steven E.

AU - Damon, Lloyd E.

AU - Lancet, Jeffrey

AU - Maness-Harris, Lori J

AU - Marcucci, Guido

AU - Martin, Michael G.

AU - Millenson, Michael M.

AU - Moore, Joseph O.

AU - Ravandi, Farhad

AU - Shami, Paul J.

AU - Smith, B. Douglas

AU - Stone, Richard M.

AU - Strickland, Stephen A.

AU - Wang, Eunice S.

AU - Gregory, Kristina M.

AU - Naganuma, Maoko

PY - 2013/9/1

Y1 - 2013/9/1

N2 - These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

AB - These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

UR - http://www.scopus.com/inward/record.url?scp=84885093586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885093586&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2013.0127

DO - 10.6004/jnccn.2013.0127

M3 - Review article

C2 - 24029121

AN - SCOPUS:84885093586

VL - 11

SP - 1047

EP - 1055

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 9

ER -